PDF
Published
2025-10-30
Section
Articles
How to Cite
КЕЧГИ РЕПРОДУКТИВ ДАВРДА АЁЛЛАР КЎКРАК БЕЗИ САРАТОНИ ПАТОМОРФОЛОГИК ЖИХАТЛАРИ
Дилшод Аллаберганов
Тошкент давлат тиббиёт университети
Зайнаб Казакова
РИО ваРИАТМ Хоразим филиалии
Keywords: кечги репродуктив давр, кўкрак бези саратони, дуктал карцинома ва дифференциаллашмаган карцинома
Abstract
кўкрак бези саратонини кечги репродуктив даврдаги дарвда 40-50 ёшларда илк аниқланган хавфли саратонлари асосан дисгорманал бузилишлар сабали юзага келиб, таргет терапия ва кимётерапияга қийин бериладиган бўлиб, морфологик жихатлари бўйича, ўрганишни талаб этади. Бу эса, кўкрак бези саратони дуктал, бўлакча карциномаси ва мезенхимал хавфли турлари бўлиб, асосий жихатлари без эпителийларида пролифератив фаол ўчоқларни кўп бўлиши дифференциаллашмаган атпики хужайраларни массив кўпайиши, метастазланиш даражаси устунлиги билан намоён бўлиб, ўсма хужайраларни токсик захарлаш даражасини устунлиги билан характерланади. Дуктал карциномада етилмаган хужайраларни дифференциаллашмаган турларини кўпайиши пролифератив инлдексни устунлигидан далолат беради
References
1. Staller P, Sulitkova J, Lisztwan J, Moch H, Oakeley EJ, Krek W. Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL. Nature 2003; 425:307-311.
2. Sokolenko A.P., Savonevich E.L., Ivantsov A.O. et al. Rapid selection of BRCA1-proficient tumor cells during neoadjuvant therapy for ovarian cancer in BRCA1 mutation carriers // Cancer Letters. – 2017. – Vol. 397. – P. 127–132.
3. Sotiriou C, Wirapati P, Loi S et al. // Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis.- J Natl Cancer Inst.- 2006.- 98(4) p.262–272.
4. Symmans WF, Hatzis C, Liedtke C et al. // Use of genomic grade index (GGI) to predict pathologic response to preoperative chemotherapy in breast cancer.- J Clin Oncol 2008.- 26 (Suppl): (Abstr 541).
5. Stacker S.A., Caesar C., Baldwin M.E. et al. Vascular endothelial growth factor-D promotes the metastatic spread of cancer via the lymphatics // Nature Med. - 2001. - Vol. 7. - P. 186-191.
6. Schwartz R.S., Erban J.K. Timing of Metastasis in Breast Cancer // the New England Journal of Medicine. – 2017. – Vol. 376. – № 25. – P. 2486–2488.
7. Sokolenko A., Imyanitov E. Multigene testing for breast cancer risk assessment: an illusion of added clinical value // Chinese Clinical Oncology. – 2017. – Vol. 6. – № 2. – P. 15.
8. Servick K. Breast cancer. Breast cancer: a world of differences // Science. – 2014. – Vol. 343. – № 6178. – P. 1452–1453. 11. Nelson E.R., Wardell S.E., Jasper J.S. et al. 27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology // Science. – 2013. – Vol. 342. – № 6162. – P. 1094–1098.
9. Strange R. Apoptosis in mouse mammary gland development / R. Strange // Experientia. -1991. -№47.- P.105.
10. Ben-Hur H, Mordechay E, Halperin R, Gurevich P, Zandbank J, Herper M, Zusman I. Apoptosis-related proteins (Fas, Fas ligand, bcl-2 and p53) in different types of human breast tumors// Oncol Rep. - 2002.- V. 9, № 5.- Р. 977-80.
11. Bertho AL, Santiago MA, Coutinho SG. Flow cytometry in the study of cell death// Mem Inst Oswaldo Cruz. - 2000.- V. 95, № 3.- Р.429-33.
12. F. Dario Cuello-Carrion , Daniel R.Ciocca. Improved detection of apoptic cells using a modified in situ Tunel techique// The Journal of Histochemistry and Cytochemistry. -1999.- V. 47, № 6.- Р. 837-839.
13. Darzynkiewicz Z, Bedner E. Analysis of apoptotic cells by flow and laser scanning cytometry// Methods Enzymol. - 2000.- V. 322.- P. 18-39. Gonzalez-Campora R, Galera Ruiz MR, Vazquez Ramirez F, Rios Martin JJ, Fernandez Santos JM, Ramos Martos MM, Gomez Pascual A. Apoptosis in breast carcinoma// Pathol Res Pract. - 2000.- V. 196, № 3.- Р. 167-74.
14. Michels J.J., Duigou F., Marnay J. Flow cytometry in primary breast carcinomas. Prognostic impact of proliferative activity// Breast cancer Res. Treat. - 2000 - V. 62, № 2. Р. 117-26.
15. S.J.Choi, N.E.Atakhanova, N.R.Shayusupov, D.M.Ishakov, A.J.Kahharov. Breast cancer recurrence clinic-pathological risk factors// World journal of pharmaceutical and medical research. -Delhi, 2019 №5 (4)-P. 19-22 (14.00.00; №9).
16. Thompson E.R., Rowley S.M., Li N. et al. Panel Testing for Familial Breast Cancer: Calibrating the Tension Between Research and Clinical Care // Journal of Clinical Oncology. – 2016. – Vol. 34. – № 13. – P. 1455–1459.
17. O'Donovan N, Crown J, Stunell H, Hill AD, McDermott E, O'Higgins N, Duffy MJ. Caspase 3 in breast cancer// Clin Cancer Res. - 2003.- V. 9, № 2.- Р. 738-42
18. Peng L, Jiang H, Bradely C. Detection of B lymphoma cells undergoing apoptosis by Annexin-V assay// Chin Med Sci J. - 2002.- V. 17, № 1.- Р. 17-21.
19. Richard L. Ornberg. Proliferation and apoptosis measurements by color image analysis based on differential absorption// The Journal of Histochemistry and Cytochemistry. - 2001.- V. 49, № 8.- Р.1059-1060.
20. Schondorf T, Gohring UJ, Becker M, Hoopmann M, Schmidt T, Rutzel S, Rein DT, Ulrich U, Fechteler R, Bersch A, Mallmann P, Valter MM. High apoptotic index correlates to p21 and p27 expression indicating a favorable outcome of primary breast cancer patients, but lacking prognostic significance in multivariate analysis// Pathobiology. - 2004.- V. 71, № 4.- Р. 217-22.
21. Rouleau-Dubois C, Cuny M, Ferrieres G, Simony-Lafontaine J, Rouanet P, Grenier J, Jeanteur P, Baldet P, Escot C. Spontaneous apoptosis in the intra¬ductal component's stroma of breast invasive carcinoma// Anticancer Res. - 2004.- V. 24, № 1.- Р. 53-7.
22. Sun S., Li L., Sun D. In situ observation of apoptosis and proliferation in breast cancer and its precancerous lesions// Zhonghua Zhong Liu Za Zhi. - 1999. - V. 21, № 6.- P. 447-9.
23. Talieri M, Diamandis EP, Katsaros N, Gourgiotis D, Scorilas A. Expression of BCL2L12, a new member of apoptosis-related genes, in breast tumors// Thromb Haemost. - 2003.- V. 89, № 6.- Р. 1081-8. Mark C. Willingham. Cytochemical methods for the detection of apoptosis// The Journal of Histochemistry and Cytochemistry.-1999.- V. 47, № 9.- Р. 1101-1109.
24. Zhang SQ, Qiang SY, Yang WB, Jiang JT, Ji ZZ. [Expression of survivin in different stages of carcinogenesis and progression of breast cancer]// Ai Zheng. - 2004.- V. 23, № 6.- Р. 697-700.
